Cita APA

Phillips, M. A., White, K. L., Kokkonda, S., Deng, X., White, J., El Mazouni, F., . . . Charman, S. A. (2016). A triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor (DSM421) with improved drug-like properties for treatment and prevention of malaria. ACS Infect Dis.

Citación estilo Chicago

Phillips, Margaret A., et al. "A Triazolopyrimidine-based Dihydroorotate Dehydrogenase Inhibitor (DSM421) With Improved Drug-like Properties for Treatment and Prevention of Malaria." ACS Infect Dis 2016.

Cita MLA

Phillips, Margaret A., et al. "A Triazolopyrimidine-based Dihydroorotate Dehydrogenase Inhibitor (DSM421) With Improved Drug-like Properties for Treatment and Prevention of Malaria." ACS Infect Dis 2016.